Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC
Sara Lemoinne1,2, Nora Cazzagon3, Olivier Chazouillères1,2
1Assistance Publique-Hôpitaux de Paris, Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis (CRMR, MIVB-H), Department of Hepatology, Saint-Antoine Hospital, Paris, France.
Alimentary Pharmacology & Therapeutics
|May 24, 2021
Abstract
No abstract available in PubMed .
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.6K
06:09Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
1.5K
